Intravenous Ibuprofen Versus Ketorolac in Bariatric Surgery

• Status: Not yet recruiting
• Trial end date: 2023-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the current study is to compare the analgesic effects of both drugs in patients with obesity undergoing bariatric surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Ibuprofen; Ketorolac

Criteria

Inclusion Criteria:

• adult (18-65 years) patients

• body mass index ≥35 kg/m2

• scheduled for laparoscopic bariatric surgery

Exclusion Criteria:

• American Society of Anesthesiologists (ASA) physical class IV,

• severe cardiac comorbidity (impaired contractility with ejection fraction < 50%, heart block, significant arrhythmias, tight valvular lesions),

• known obstructive sleep apnea or patients with STOP-bang score ≥5,

• baseline SpO2 <95%,

• renal impairment,

• allergy to any of study's drugs,

• history of gastrointestinal bleeding or ulceration, or inflammatory bowel disease